- Brands Logos
- Logo Templates
- Icons
- Vectors
- Font In Logos
- Blog
Boehringer Ingelheim, which has been a family company since its establishment in 1885, is among the 20 largest companies in the pharmaceutical industry in the fields of human and animal health. Research-oriented pharmaceutical company Boehringer Ingelheim's goal is to improve health and quality of life. The biggest focus in this target is the diseases for which there is no adequate treatment option. For this purpose, the company concentrates on developing innovative treatments that will prolong life. In animal health, Boehringer Ingelheim stands out in the field of advanced preventive treatments.
With approximately 50,000 employees, Boehringer Ingelheim continues to create value by innovating in three business areas: human health drugs, animal health and biopharmaceuticals. Boehringer Ingelheim achieved a net sales value of 18.1 billion euros in 2017. It allocates 17% of its net sales to R&D expenditures. R&D expenditures exceeding three billion euros are 17 percent of net sales.
